A brief history of cerebral cavernous malformations: a personal perspective

Abstract

As is the case in many areas of medicine and science in general, there has been a dramatic acceleration in the acquisition of understanding during the last few decades. This is also the case for cerebral cavernous malformations (CCMs). We like to artificially divide the progress that we have personally witnessed into three phases: pre-magnetic resonance imaging (MRI), post-MRI, and molecular. We highlight the major leaps forward linked to the specific discovery.

Keywords

Cerebral cavernous malformations / history / developments

References

[1] McCormick WF.The pathology of vascular ("arteriovenous") malformations.J Neurosurg1966;24:807-16

[2] Zülch KJ.A. Brain tumors: their biology and pathology.Am J Med Sci1965;250:238

[3] Russell DS.Pathology of tumours of the nervous system (4th edition).Am J Surg Pathol1978;2:113

[4] Otten P,Rilliet B.131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies.Neurochirurgie35:82-131. (in French)

[5] Voigt K.Cerebral cavernous haemangiomas or cavernomas. Incidence, pathology, localization, diagnosis, clinical features and treatment. Review of the literature and report of an unusual case.Neurochirurgia (Stuttg)1976;19:59-68

[6] Giombini S.Cavernous angiomas of the brain. Account of fourteen personal cases and review of the literature.Acta Neurochir (Wien)1978;40:61-82

[7] Savoiardo M,Passerini A.Intracranial cavernous hemangiomas: neuroradiologic review of 36 operated cases.Am J Neuroradiol1983;4:945-50.

[8] Vaquero J,Martínez R.Cavernomas of the brain.Neurosurgery1983;12:208-10

[9] Bruhlmann Y,Berney J.Les angiomes caverneux intracérébraux.Neurochirurgie1985;31:271-9. (in French)

[10] Simard JM,Ballinger WE Jr,Quisling RG.Cavernous angioma: a review of 126 collected and 12 new clinical cases.Neurosurgery1986;18:162-72

[11] Tagle P,Méndez J.Intracranial cavernous angioma: presentation and management.J Neurosurg1986;64:720-3

[12] Salman RA,Horne MA.Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study.Lancet Neurol2012;11:217-24 PMCID:PMC3282211

[13] Radvany MG,Gailloud P.Angiographic detection of cerebral cavernous malformations with C-arm cone beam CT imaging in three patients.J Neurointerv Surg2014;6:e17

[14] Bell BA,Symon L.Angiographically occult arteriovenous malformations of the brain.J Neurol Neurosurg Psychiatry1978;41:1057-64 PMCID:PMC493231

[15] Becker DH,Kramer RA.Occult cerebrovascular malformations. A series of 18 histologically verified cases with negative angiography.Brain1979;102:249-87

[16] Sadeh M,Rappaport Z.Surgical extirpation of a venous angioma of the medulla oblongata simulating multiple sclerosis.Surg Neurol1982;17:334-7

[17] Senegor M,Wollmann RL.Venous angiomas of the posterior fossa should be considered as anomalous venous drainage.Surg Neurol1983;19:26-32

[18] Hayman LA,Ferrell RE,Ostrow P.Familial cavernous angiomas: natural history and genetic study over a 5-year period.Am J Med Genet1982;11:147-60

[19] Rigamonti D,Johnson PC,Zabramski J.The MRI appearance of cavernous malformations (angiomas).J Neurosurg1987;67:518-24

[20] Morris Z,Longstreth WT Jr.Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis.BMJ2009;339:b3016 PMCID:PMC2728201

[21] Flemming KD.Incidence, prevalence, and clinical presentation of cerebral cavernous malformations.Methods Mol Biol2020;2152:27-33

[22] Rigamonti D.The association of venous and cavernous malformations. Report of four cases and discussion of the pathophysiological, diagnostic, and therapeutic implications.Acta Neurochir (Wien)1988;92:100-5

[23] Rigamonti D,Spetzler RF.Extracerebral cavernous angiomas of the middle fossa.Neurosurgery1990;27:306-10

[24] Smith ER,Rigamonti D.Surgical treatment of cavernous malformations in children. In: Rigamonti D, editor. Cavernous malformations of the nervous system. Cambridge: Cambridge University Press; 2011. p. 135-42.

[25] Rigamonti D,Drayer BP.Appearance of venous malformations on magnetic resonance imaging.J Neurosurg1988;69:535-9

[26] Rigamonti D,Medina M,Geckle DS.Cerebral venous malformations.J Neurosurg1990;73:560-4

[27] Rigamonti D,Spetzler RF,Drayer BP.Cavernous malformations and capillary telangiectasia: a spectrum within a single pathological entity.Neurosurgery1991;28:60-4

[28] Lee RR,Benson ML.Brain capillary telangiectasia: MR imaging appearance and clinicohistopathologic findings.Radiology1997;205:797-805.

[29] Naff NJ,Hoenig-Rigamonti K.A longitudinal study of patients with venous malformations: documentation of a negligible hemorrhage risk and benign natural history.Neurology1998;50:1709-14

[30] Clatterbuck RE,Elmaci I,Breiter SN.Dynamic nature of cavernous malformations: a prospective magnetic resonance imaging study with volumetric analysis.J Neurosurg2000;93:981-6

[31] Moriarity JL,Rigamonti D.The natural history of cavernous malformations.Neurosurg Clin N Am1999;10:411-7

[32] Moriarity JL,Clatterbuck RE.The natural history of cavernous malformations: a prospective study of 68 patients.Neurosurgery1999;44:1166-71

[33] Clatterbuck RE,Crain BJ.Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations.J Neurol Neurosurg Psychiatry2001;71:188-92 PMCID:PMC1737494

[34] Clatterbuck RE,Rigamonti D.The nature and fate of punctate (Type IV) cavernous malformations.Neurosurgery2001;49:26-32

[35] Kharkar S,Conway J.The natural history of conservatively managed symptomatic intramedullary spinal cord cavernomas.Neurosurgery2007;60:865-72; discussion 865

[36] Batra S,Recinos PF,Rigamonti D.Cavernous malformations: natural history, diagnosis and treatment.Nat Rev Neurol2009;5:659-70

[37] Zabramski JM,Spetzler RF.The natural history of familial cavernous malformations: results of an ongoing study.J Neurosurg1994;80:422-32

[38] Souza JM, Domingues RC, Cruz LC Jr, Domingues FS, Iasbeck T, Gasparetto EL. Susceptibility-weighted imaging for the evaluation of patients with familial cerebral cavernous malformations: a comparison with t2-weighted fast spin-echo and gradient-echo sequences.AJNR Am J Neuroradiol2008;29:154-8 PMCID:PMC8119083

[39] Rivera PP,Porter PJ.Intracranial cavernous malformations.Neuroimaging Clin N Am2003;13:27-40

[40] Li KW,Clatterbuck RE,Rigamonti D.Superficial siderosis associated with multiple cavernous malformations: report of three cases.Neurosurgery2001;48:1147-51

[41] Beechar VB,Reznik OE.Intraventricular cavernomas of the third ventricle: report of 2 cases and a systematic review of the literature.World Neurosurg2017;105:935-943.e3

[42] Detwiler PW,Zabramski JM.De novo formation of a central nervous system cavernous malformation: implications for predicting risk of hemorrhage. Case report and review of the literature.J Neurosurg1997;87:629-32

[43] Nimjee SM,Bulsara KR.Review of the literature on de novo formation of cavernous malformations of the central nervous system after radiation therapy.Neurosurg Focus2006;21:e4

[44] Rosenblum JS,Al-Khalili Y,Veznedaroglu E.Unilateral symptomatic hypertrophic olivary degeneration secondary to midline brainstem cavernous angioma: a case report and review of the literature.World Neurosurg2018;110:294-300

[45] Rigamonti D,Drayer BP.Cerebral cavernous malformations. Incidence and familial occurrence.N Engl J Med1988;319:343-7

[46] Flemming KD,Meyer FB.Aggressive course of multiple de novo cavernous malformations.J Neurosurg2011;115:1175-8

[47] Gastelum E,Hills N.Rates and characteristics of radiographically detected intracerebral cavernous malformations after cranial radiation therapy in pediatric cancer patients.J Child Neurol2015;30:842-9 PMCID:PMC4326593

[48] Clatterbuck RE,Rigamonti D.The juxtaposition of a capillary telangiectasia, cavernous malformation, and developmental venous anomaly in the brainstem of a single patient: case report.Neurosurgery2001;49:1246-50

[49] Clatterbuck RE,Gailloud P,Rigamonti D.Vertebral hemangiomas associated with familial cerebral cavernous malformation: segmental disease expression. Case report.J Neurosurg2002;97:227-30

[50] Polymeropoulos MH,Hsu F.Linkage of the locus for cerebral cavernous hemangiomas to human chromosome 7q in four families of Mexican-American descent.Neurology1997;48:752-7

[51] Zhang J,Rigamonti D.Mutations in KRIT1 in familial cerebral cavernous malformations.Neurosurgery2000;46:1272-7; discussion 1277

[52] Zhang J,Rigamonti D.Cloning of the murine Krit1 cDNA reveals novel mammalian 5' coding exons.Genomics2000;70:392-5

[53] Zhang J,Rigamonti D,Dietz HC.Interaction between krit1 and icap1alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation.Hum Mol Genet2001;10:2953-60

[54] Zhang J,Dietz HC.Interaction between krit1 and malcavernin: implications for the pathogenesis of cerebral cavernous malformations.Neurosurgery2007;60:353-9; discussion 359

[55] Zhang J,Rigamonti D,Clatterbuck RE.Krit1 modulates beta 1-integrin-mediated endothelial cell proliferation.Neurosurgery2008;63:571-8; discussion 578

[56] Liu H,Badr A.Ccm1 assures microvascular integrity during angiogenesis.Trans Stroke Res2010;1:146-53 PMCID:PMC3090208

[57] Zhang J,Rigamonti D.Genome-wide linkage scan maps ETINPH gene to chromosome 19q12-13.31.Hum Hered2010;69:262-7

[58] Liu H,Badr A.Ccm1 regulates microvascular morphogenesis during angiogenesis.J Vasc Res2011;48:130-40 PMCID:PMC3219476

[59] Bergametti F,Labauge P.Société Française de NeurochirurgieMutations within the programmed cell death 10 gene cause cerebral cavernous malformations.Am J Hum Genet2005;76:42-51 PMCID:PMC1196432

[60] Denier C,Bergametti F.Société Française de NeurochirurgieGenotype-phenotype correlations in cerebral cavernous malformations patients.Ann Neurol2006;60:550-6

[61] Spiegler S,Paperlein C.Cerebral cavernous malformations: an update on prevalence, molecular genetic analyses, and genetic counselling.Mol Syndromol2018;9:60-9 PMCID:PMC5836221

[62] Stenson PD,Ball EV.The Human Gene Mutation Database (HGMD^®): optimizing its use in a clinical diagnostic or research setting.Hum Genet2020;139:1197-207 PMCID:PMC7497289

[63] Corr M,Keubel JM.Decreased Krev interaction-trapped 1 expression leads to increased vascular permeability and modifies inflammatory responses in vivo.Arterioscler Thromb Vasc Biol2012;32:2702-10 PMCID:PMC3475761

[64] Draheim KM,Boggon TJ.Cerebral cavernous malformation proteins at a glance.J Cell Sci2014;127:701-7 PMCID:PMC3924200

[65] Fisher OS.Signaling pathways and the cerebral cavernous malformations proteins: lessons from structural biology.Cell Mol Life Sci2014;71:1881-92 PMCID:PMC3999170

[66] Draheim KM,Zhang R.CCM2-CCM3 interaction stabilizes their protein expression and permits endothelial network formation.J Cell Biol2015;208:987-1001 PMCID:PMC4384732

[67] Shenkar R,Rebeiz T.Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations.Genet Med2015;17:188-96 PMCID:PMC4329119

[68] Jenny Zhou H,Zhang H.Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation.Nat Med2016;22:1033-42 PMCID:PMC5014607

[69] Vos IJ, Vreeburg M, Koek GH, van Steensel MA. Review of familial cerebral cavernous malformations and report of seven additional families.Am J Med Genet A2017;173:338-51

[70] Abou-Fadel J,Gonzalez EM,Zhang J.Emerging roles of CCM genes during tumorigenesis with potential application as novel biomarkers across major types of cancers.Oncol Rep2020;43:1945-63 PMCID:PMC7160551

[71] Orsenigo F,Jauhiainen S.Mapping endothelial-cell diversity in cerebral cavernous malformations at single-cell resolution.Elife2020;9:e61413 PMCID:PMC7609066

[72] Peng W,Feng D.Cerebral cavernous malformation 3 relieves subarachnoid hemorrhage-induced neuroinflammation in rats through inhibiting NF-kB signaling pathway.Brain Res Bull2020;160:74-84

[73] Su VL.Signalling through cerebral cavernous malformation protein networks.Open Biol2020;10:200263 PMCID:PMC7729028

[74] Wei S,Polster SP,Awad IA.Cerebral cavernous malformation proteins in barrier maintenance and regulation.Int J Mol Sci2020;21:675 PMCID:PMC7013531

[75] Ricci C,Riolo G,Battistini S.KRIT1 gene in patients with cerebral cavernous malformations: clinical features and molecular characterization of novel variants.J Mol Neurosci2021;

[76] Riolo G,Battistini S.Molecular genetic features of cerebral cavernous malformations (CCM) Patients: an overall view from genes to endothelial cells.Cells2021;10:704 PMCID:PMC8005105

[77] Cuttano R,Bravi L.KLF4 is a key determinant in the development and progression of cerebral cavernous malformations.EMBO Mol Med2016;8:6-24 PMCID:PMC4718159

[78] Padarti A.Recent advances in cerebral cavernous malformation research.Vessel Plus2018;2:21 PMCID:PMC6663315

[79] Abou-Fadel J,Grajeda B,Zhang J.Systems-wide analysis unravels the new roles of CCM signal complex (CSC).Heliyon2019;5:e02899 PMCID:PMC6909108

[80] Jiang X,Qu Y.Alternatively spliced isoforms reveal a novel type of PTB domain in CCM2 protein.Sci Rep2019;9:15808 PMCID:PMC6825194

[81] Awad IA.Cavernous angiomas: deconstructing a neurosurgical disease.J Neurosurg2019;131:1-13 PMCID:PMC6778695

[82] De Luca E,Moglianetti M.Multifunctional platinum@BSA-rapamycin nanocarriers for the combinatorial therapy of cerebral cavernous malformation.ACS Omega2018;3:15389-98 PMCID:PMC6288776

[83] Marchi S,Trapani E.Defective autophagy is a key feature of cerebral cavernous malformations.EMBO Mol Med2015;7:1403-17 PMCID:PMC4644374

[84] Ren AA,Su YS.PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism.Nature2021;594:271-6

[85] Akers A,A Awad I.Synopsis of guidelines for the clinical management of cerebral cavernous malformations: consensus recommendations based on systematic literature review by the angioma alliance scientific advisory board clinical experts panel.Neurosurgery2017;80:665-80 PMCID:PMC5808153